The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Placebo-Controlled Trial of Sertraline in the Treatment of Children With Generalized Anxiety Disorder
Abstract
OBJECTIVE: The study compared the safety and efficacy of sertraline, a selective serotonin reuptake inhibitor, and placebo in the treatment of generalized anxiety disorder in children and adolescents. METHOD: The study subjects were 22 children and adolescents age 5-17 years who met the DSM-IV criteria for generalized anxiety disorder according to the Anxiety Disorders Interview Schedule for Children-Revised and who had a Hamilton Anxiety Rating Scale score > or = 16. The patients underwent a 2-3-week prestudy evaluation period, followed by a 9-week double-blind treatment phase in which they were randomly assigned in blocks of four to receive either sertraline or pill placebo. The maximum dose of sertraline was 50 mg/day. Primary outcome measures were the Hamilton anxiety scale and the Clinical Global Impression scale. RESULTS: The Hamilton anxiety scale total score, psychic factor, and somatic factor and the Clinical Global Impression severity and improvement scales showed significant differences with treatment in favor of sertraline over placebo beginning at week 4. Self-report measures reflected these results at the end of treatment. CONCLUSIONS: The results of this double-blind, placebo-controlled trial suggest that sertraline at the daily dose of 50 mg is safe and efficacious for the treatment of generalized anxiety disorder in children and adolescents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
(2001) · Statistics for Psychologists · doi:10.4324/9781410605542-11 · Cited by 6,877
The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity
MARCH, J. S., PARKER, J. D. A., SULLIVAN, K., STALLINGS, P., & CONNERS, C. K. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199704000-00019 · Cited by 2,236
What I Think and Feel: A Revised Measure of Children's Manifest Anxiety
Reynolds, C. R., & Richmond, B. O. (1997) · Journal of Abnormal Child Psychology · doi:10.1023/a:1025751206600 · Cited by 1,935
Angold, A., Costello, E. J., & Erkanli, A. (1999) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00424 · Cited by 1,872
What i think and feel: A revised measure of children's manifest anxiety
Reynolds, C. R., & Richmond, B. O. (1978) · Journal of Abnormal Child Psychology · doi:10.1007/bf00919131 · Cited by 1,741
Lewinsohn, P. M., Hops, H., Roberts, R. E., Seeley, J. R., & Andrews, J. A. (1993) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.102.1.133 · Cited by 1,547
Anderson, J. C. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800130081010 · Cited by 1,457
Trends in the Prescribing of Psychotropic Medications to Preschoolers
Zito, J. M. (2000) · JAMA · doi:10.1001/jama.283.8.1025 · Cited by 863
Cited by
Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety
Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., Ginsburg, G. S., Rynn, M. A., McCracken, J., Waslick, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804633 · Cited by 1,442
Self-citationKatzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Connolly, S. D., & Bernstein, G. A. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000246070.23695.06 · Cited by 548
Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents
Olfson, M. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.10.978 · Cited by 430
Fluoxetine for the Treatment of Childhood Anxiety Disorders
BIRMAHER, B., AXELSON, D. A., MONK, K., KALAS, C., CLARK, D. B., EHMANN, M., BRIDGE, J., HEO, J., & BRENT, D. A. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000037049.04952.9f · Cited by 385
Locher, C., Koechlin, H., Zion, S. R., Werner, C., Pine, D. S., Kirsch, I., Kessler, R. C., & Kossowsky, J. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.2432 · Cited by 360
“Two studies(22,23) did not include SDs or SEs, and they were imputed by way of the leaving-1-out method.(24) Data were extracted independently by 3 of us (C.”
Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods
Compton, S. N., Walkup, J. T., Albano, A. M., Piacentini, J. C., Birmaher, B., Sherrill, J. T., Ginsburg, G. S., Rynn, M. A., McCracken, J. T., Waslick, B. D., et al. (2010) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-4-1 · Cited by 336
Self-citationAssessment and Treatment of Anxiety Disorders in Children and Adolescents
Wehry, A. M., Beesdo-Baum, K., Hennelly, M. M., Connolly, S. D., & Strawn, J. R. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0591-z · Cited by 294
Strawn, J. R., Geracioti, L., Rajdev, N., Clemenza, K., & Levine, A. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1491966 · Cited by 214
Rief, W., Nestoriuc, Y., von Lilienfeld-Toal, A., Dogan, I., Schreiber, F., Hofmann, S. G., Barsky, A. J., & Avorn, J. (2009) · Drug Safety · doi:10.2165/11316580-000000000-00000 · Cited by 202
Strawn, J. R., Welge, J. A., Wehry, A. M., Keeshin, B., & Rynn, M. A. (2015) · Depression and Anxiety · doi:10.1002/da.22329 · Cited by 183
Self-citationResearch Review: Pediatric Anxiety Disorders—What Have We Learnt in the Last 10 Years?
Strawn, J. R., Lu, L., Peris, T. S., Levine, A., & Walkup, J. T. (2021) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13262 · Cited by 168
The psychometric properties of the MASC in a pediatric psychiatric sample
Rynn, M. A., Barber, J. P., Khalid-Khan, S., Siqueland, L., Dembiski, M., McCarthy, K. S., & Gallop, R. (2006) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2005.01.004 · Cited by 138
Self-citationSiqueland, L., Rynn, M., & Diamond, G. S. (2005) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2004.04.006 · Cited by 134
Self-citationMediators of change in the Child/Adolescent Anxiety Multimodal Treatment Study.
Kendall, P. C., Cummings, C. M., Villabø, M. A., Narayanan, M. K., Treadwell, K., Birmaher, B., Compton, S., Piacentini, J., Sherrill, J., Walkup, J., et al. (2016) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0039773 · Cited by 118
Anxiety Disorders in Children and Adolescents
Rockhill, C., Kodish, I., DiBattisto, C., Macias, M., Varley, C., & Ryan, S. (2010) · Current Problems in Pediatric and Adolescent Health Care · doi:10.1016/j.cppeds.2010.02.002 · Cited by 110
The evidence-based pharmacotherapy of social anxiety disorder
Blanco, C., Bragdon, L. B., Schneier, F. R., & Liebowitz, M. R. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000119 · Cited by 99
Strawn, J. R., Mills, J. A., Sauley, B. A., & Welge, J. A. (2018) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2018.01.015 · Cited by 98
Offidani, E., Fava, G. A., Tomba, E., & Baldessarini, R. J. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000345316 · Cited by 94
Neurostructural abnormalities in pediatric anxiety disorders
Strawn, J. R., Hamm, L., Fitzgerald, D. A., Fitzgerald, K. D., Monk, C. S., & Phan, K. L. (2015) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2015.03.004 · Cited by 81
Pine, D. S. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760386888 · Cited by 73
Predictors of treatment response in anxious-depressed adolescents with school refusal
LAYNE, A. E., BERNSTEIN, G. A., EGAN, E. A., & KUSHNER, M. G. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200303000-00012 · Cited by 73
The pharmacological management of childhood anxiety disorders: a review
Reinblatt, S. P., & Riddle, M. A. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0644-4 · Cited by 67
Rickels, K., Etemad, B., Khalid-Khan, S., Lohoff, F. W., Rynn, M. A., & Gallop, R. J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.170 · Cited by 63
Self-citationPharmacotherapy for anxiety disorders in children and adolescents
Kodish, I., Rockhill, C., & Varley, C. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.4/ikodish · Cited by 62
Strawn, J. R., Compton, S. N., Robertson, B., Albano, A. M., Hamdani, M., & Rynn, M. A. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0132 · Cited by 55
Self-citationAnxiety and Anxiety Disorders in Girls
Albano, A. M., & Krain, A. (2005) · Issues in Clinical Child Psychology · doi:10.1007/0-306-48674-1_3 · Cited by 35
da Costa, C. Z. G., de Morais, R. M. C. B., Zanetta, D. M. T., Turkiewicz, G., Neto, F. L., Morikawa, M., Rodrigues, C. L., Labbadia, E. M., & Asbahr, F. R. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0110 · Cited by 31
Cochrane review: Cognitive behavioural therapy for anxiety disorders in children and adolescents
James, A., Soler, A., & Weatherall, R. (2007) · Evidence-Based Child Health: A Cochrane Review Journal · doi:10.1002/ebch.206 · Cited by 20
Hoge, E. A., Oppenheimer, J. E., & Simon, N. M. (2004) · Focus · doi:10.1176/foc.2.3.346 · Cited by 19
Psychopharmacology Interventions for Pediatric Anxiety Disorders: A Research Update
Waslick, B. (2006) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2005.08.009 · Cited by 17
“In a small (n = 22) RCT examining the efficacy of sertraline for children and adolescents who had primary GAD, Rynn and colleagues [17] found”
BackgroundAdvances in Pharmacotherapy for Pediatric Anxiety Disorders
Nicotra, C. M., & Strawn, J. R. (2023) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2023.02.006 · Cited by 16
(2017) · doi:10.23970/ahrqepccer192 · Cited by 5
The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder
Castagna, P. J., Farahdel, E., Potenza, M. N., & Crowley, M. J. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2199921 · Cited by 3
Psychopharmacology for Social Anxiety Disorder
Blanco, C., Bragdon, L., Schneier, F. R., & Liebowitz, M. R. (2014) · Social Anxiety · doi:10.1016/b978-0-12-394427-6.00022-4 · Cited by 2
Anxiety and Fear-Related Disorders: Generalized Anxiety Disorder
Rosellini, A. J., & Brown, T. A. (2024) · Tasman’s Psychiatry · doi:10.1007/978-3-030-51366-5_74 · Cited by 1
Metadata
- Authors
- Rynn, M. A., Siqueland, L., & Rickels, K.
- Venue
- American Journal of Psychiatry
- Published
- 2001-12-01
- Volume
- 158
- Issue
- 12
- Pages
- 2008-2014
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2106020208
- Cited by
- 321
- References
- 39
- FWCI
- 22.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.